{'fraction_non_alphanumeric': 0.030987734021949646, 'fraction_numerical': 0.001936733376371853, 'mean_word_length': 5.485355648535565, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
New Publication: Financial Management for Pharmacists: A Decision-Making Approach, 2nd Edition

Geriatric Drug Therapy Interven­ tions is a compilation of a variety of data on drug therapy utilization in the elderly. This 73-page book includes a review article with the same title as the book, three re­ search articles examining pharma­ ceutical interventions in three geri­ atric practice settings, and a case report of costs associated with failed interventions. The first section, "Geriatric Drug Therapy Interventions," provides background information on the overall health status of geriatric Americans and considers the im­ pact of managed care. The influ­ ence of drug-related problems (DRPs) on geriatric hospital admis­ sions is discussed for ambulatory, hospitalized, and nursing-home patients. Some risk factors include patient misunderstanding of the outpatient drug regimen, nosoco­ mial drug administration errors, polypharmacy, and a lack of rigor­ ous regimen reviews. Significant DRPs have also been noted in adult day-care settings. DRPs are categorized by noncompliance and adverse effects. Reasons for noncompliance from the view­ points of both the patient and clini­ cian are addressed. A concise re­ view of improvements made in the pharmaceutical industry and feder­ al regulations to influence geriatric prescribing is provided. Given the outcome orientation of the health­ care industry today, the author identifies a variety of pharmaceuti­ cal outcomes with shared responsi­ bilities by pharmacists and other clinicians.